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The trans-Golgi matrix consists of a group of proteins dynamically associated with the trans-Golgi and thought to be
involved in anterograde and retrograde Golgi traffic, as well as interactions with the cytoskeleton and maintenance of the
Golgi structure. GMx33 is localized to the cytoplasmic face of the trans-Golgi and is also present in a large cytoplasmic
pool. Here we demonstrate that GMx33 is dynamically associated with the trans-Golgi matrix, associating and dissoci-
ating with the Golgi in seconds. GMx33 can be locked onto the trans-Golgi matrix by GTPS, indicating that its
association is regulated in a GTP-dependent manner like several other Golgi matrix proteins. Using live-cell imaging we
show that GMx33 exits the Golgi associated with tubules and within these tubules GMx33 segregates from transmem-
brane proteins followed by fragmentation of the tubules into smaller tubules and vesicles. Within vesicles produced by
an in vitro budding reaction, GMx33 remains segregated in a matrixlike tail region that sometimes contains Golgin-245.
This trans-matrix often links a few vesicles together. Together these data suggest that GMx33 is a member of the
trans-Golgi matrix and offer clues regarding the role of the trans-Golgi matrix in sorting and exit from the Golgi.
INTRODUCTION
The Golgi matrix was described biochemically in 1994 as a
detergent-insoluble network (Slusarewicz et al., 1994), which
was hypothesized to function in maintenance of Golgi struc-
ture and to promote the formation of new stacked cisternae
after mitosis (Barr et al., 1997; Shorter and Warren, 1999;
Shorter et al., 1999; Seemann et al., 2000). A “matrixlike
material” between and around Golgi cisternae was observed
in all electron microscopy (EM) studies and was emphasized
by early microscopists (Mollenhauer, 1965; Amos and Grim-
stone, 1968). In the intervening years many Golgi-matrix
proteins have been identified and localized to the cis-, me-
dial- and trans-regions of the Golgi ribbon (Barr and Short,
2003; Gillingham and Munro, 2003). Many Golgi matrix
proteins have no transmembrane domain and associate with
the cytosolic face of Golgi membranes, whereas a few are
transmembrane proteins. The unifying structural feature of
Golgi matrix proteins is their large coiled-coil domains and
primarily based on this feature it has been suggested that
most Golgi matrix proteins be included in the Golgin family,
proteins originally identified as Golgi-localized autoanti-
gens (Fritzler et al., 1984; Barr and Short, 2003; Nozawa et al.,
2005).
It is becoming increasingly apparent that many Golgi
matrix proteins are dynamic, associating and dissociating
with membranes in seconds (Ward et al., 2001; Brandon et al.,
2003) and are more diverse in function than first predicted.
In addition to their role in cisternal stacking, the Golgi
matrix has been implicated in vesicle tethering and ER to
Golgi transport (reviewed in Lupashin and Sztul, 2005), as
well as exit from the trans-Golgi and regulation of endo-
some-to-Golgi transport (Brown et al., 2001; Yoshino et al.,
2003; Kakinuma et al., 2004; Lu et al., 2004; Yoshino et al.,
2005). One cis-Golgi matrix protein, GM130, has been de-
scribed as a docking site for signaling molecules (Preisinger
et al., 2004) and another, p115, may play a role in initiating
Golgi fragmentation during apoptosis (Chiu et al., 2002).
Recently, we have shown that several cis- and medial Golgi
matrix proteins move associated with tubules to ER exit
sites, adding to the evidence that these proteins interact with
membrane structures other than stacked cisternae (Mar-
dones et al., 2005). An even broader functional heterogeneity
for Golgi matrix proteins is anticipated as more data become
available and suggests our current definition of the Golgi
matrix might need to be broadened.
The trans-Golgi matrix proteins and their functions are
less well defined than those of the cis-medial Golgi. Cur-
rently, the trans-Golgi matrix consists of GRIP family pro-
teins, p230/Golgin-245, Golgin97, GCC88, and GCC185, and
Bicaudal-D 1 and 2 (Kjer-Nielsen et al., 1999; Munro and
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Nichols, 1999; Matanis et al., 2002; Luke et al., 2003). Bicaudal
D 1 and 2 have been shown to interact with the dynein-
dynactin complex and participate in COPI-independent ret-
rograde traffic (Hoogenraad et al., 2001; Matanis et al., 2002;
Hoogenraad et al., 2003). The GRIP-containing proteins, on
the other hand, have been implicated in exit from the Golgi
as well as retrograde traffic from endosomes to the Golgi
(Gleeson et al., 1996; Brown et al., 2001; Kakinuma et al., 2004;
Lu et al., 2004; Yoshino et al., 2005). Each GRIP protein is
thought to have distinct properties (Derby et al., 2004). For
all known GRIP proteins, the GRIP domain alone is suffi-
cient for Golgi targeting (Kjer-Nielsen et al., 1999; Munro and
Nichols, 1999; McConville et al., 2002). However, GRIP pro-
tein recruitment may be regulated in different ways (Derby
et al., 2004). In the best characterized interaction leading to
Golgi targeting, the GRIP domain interacts directly with
Arl-1 in a GTP-regulated and brefeldin A (BFA)-sensitive
manner and Arl-1 targets the complex to the Golgi (Lu and
Hong, 2003; Panic et al., 2003a, 2003b; Wu et al., 2004). One
GRIP domain-containing protein, Golgin-245 (p230, tGolgin-
1), has been found associated with vesicles budding from the
trans-Golgi and implicated in exit from the Golgi and trans-
port to the Golgi from endosomes, perhaps through its
interactions with MACF, a large molecule thought to bridge
microtubules and actin (Erlich et al., 1996; Gleeson et al.,
1996; Kakinuma et al., 2004; Yoshino et al., 2005).
GMx33 was identified through a proteomic analysis of
detergent-insoluble proteins in an isolated Golgi fraction
(Wu et al., 2000). GMx33 is conserved from yeast to mam-
mals and there are two known forms,  and , which are
very homologous to each other and similarly localized.
GMx33 is highly posttranslationally modified, peripherally
associated with the trans-Golgi and present in a cytoplasmic
pool. The human orthologues of GMx33 and  (GPP34 and
GPP34R, respectively) were simultaneously identified
through a separate proteomic analysis and described as a
Golgi-localized coatlike protein (Bell et al., 2001). Unlike
most Golgi matrix proteins, GMx33 is relatively small (33
kDa) and lacks an extensive coiled-coil structure, although it
is predicted to have three coiled domains. Almost nothing is
known about the function of GMx33. Its yeast homologue,
Vps74p, has been implicated in an interaction with Vps26p,
a member of the yeast retromer complex (Bonangelino et al.,
2002). Deletion of vps74 results in a modest mis-sorting of
the vacuolar protein carboxypeptidase Y.
Further characterization suggests that GMx33 is the pre-
dominant form expressed in HeLa and NRK cells. Fluores-
cence recovery after photobleaching (FRAP) data show that
GMx33 is highly dynamic, rapidly moving between mem-
brane and cytosolic pools. GMx33 is associated with tu-
bules exiting the trans-Golgi and appears to sort into distinct
domains along the length of these tubules before the fission
of the tubules from the Golgi. Finally, biochemistry and
immunoelectron microscopy reveals that GMx33 localizes to
matrixlike structures associated with and between budded
vesicles and tubulovesicular structures. Our data suggest
that GMx33 is a part of the trans-Golgi matrix despite its
unique properties.
MATERIALS AND METHODS
Cell Lines and DNA Constructs
NRK cells were used for all transfection and immunofluorescence experi-
ments described. A GFP-GMx33 construct was described previously (Wu et
al., 2000). GFP-GRASP55 and GFP-GRASP65 (Barr et al., 1998; Shorter et al.,
1999) were kindly provided by Francis Barr (Max-Planck Institute of Biochem-
istry, Martinsreid, Germany).
Cell Culture and Transfection
NRK cells were grown in DMEM supplemented with 10% fetal calf serum
(FCS; Hyclone, Logan, UT), penicillin and streptomycin (GIBCO-Invitrogen,
Grand Island, NY). BFA (5 g/ml final) or ammonium chloride (50 mM final)
were added directly to the culture media and incubated for the indicated
lengths of time. For inhibition of endocytosis, cells were either incubated for
2 h in complete media supplemented with glacial acetic acid to a final pH of
5 (40 mM glacial acetic acid from Fisher Scientific (Pittsburgh, PA; Cosson
et al., 1989) or were potassium depleted essentially as described (Larkin et al.,
1983; Salazar and Gonzalez, 2002). Briefly, cells were rinsed two times in
buffer A (20 mM HEPES, pH 7.4, 140 mM NaCl, 1 mM CaCl2, 1 mM MgCl2)
and then incubated in hypotonic media (buffer A diluted 1:1 in water) for 5
min. Cells were then rinsed once more in buffer A and then incubated in
buffer A for 2 h before imaging.
Transient and stable transfections were performed using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions.
Transiently transfected cells were typically visualized 6–8 h after transfection.
Stable cell lines were produced by selection for Geneticin resistance at 500
g/ml (GIBCO-Invitrogen) and were maintained in Geneticin throughout the
culture period.
RNA Interference
SMARTpools of small interference RNA (siRNA) specific for GMx33,
GMx33, and lamin were purchased from Dharmacon (Lafayette, CO) and
suspended at 2 M according to the manufacturer’s instructions. NRK cells
were grown to confluency in a 24-well plate and transfected with 100 nM of
each siRNA using DharmaFECT 1 according to the manufacturer’s instruc-
tions (Dharmacon) and OptiMEM (GIBCO-Invitrogen). Cells were incubated
in a total transfection volume of 200 l for 2 h before complete media was
added. After 24 h, the cells were split 1:4 onto coverslips in a new 24-well
plate and cultured for another 72 h before fixation and preparation for
immunofluorescence as described below.
Immunofluorescence
Immunofluorescence microscopy was carried out using cells grown on cov-
erslips overnight and fixed by a 3-min incubation in 100% methanol at room
temperature. Fixed cells were rinsed in phosphate-buffered saline (PBS) and
blocked for 30 min at room temperature or overnight at 4°C with a solution
of 0.2% BSA and 0.1% gelatin in PBS. The following monoclonal antibodies
were used to localize specific molecules: 2F7 (anti-TGN38; Horn and Banting,
1994), GM10 (anti-rat LAMP-I; Reaves et al., 1996) kindly provided by John
Hutton (University of Colorado), and H68.4 (anti-transferrin receptor,
Zymed, South San Francisco, CA). Polyclonal human autoimmune sera that
recognizes Golgin-245 (G4 anti-p230, courtesy of Alfonso Gonzalez) and
polyclonal rabbit anti-GMx33 antisera have been described elsewhere (Kre-
itzer et al., 2000; Wu et al., 2000). Primary antibodies were detected with either
anti-mouse or anti-rabbit secondary antibodies conjugated to either Alexa
Fluor 488 or Alexa Fluor 594 (Invitrogen, Carlsbad, CA). Primary and sec-
ondary incubations were carried out at 37°C for 20–30 min. Cells were
washed in 100–200 ml PBS between and after antibody incubations. During
the secondary staining, nuclei were stained with 0.3 M DAPI (Invitrogen).
Coverslips were immersed (cells down) in Fluoromount G (Electron Micros-
copy Systems, Washington, PA) on glass slides and baked for 15 min at 65°C.
Images were obtained with an inverted Zeiss Axiovert 200M deconvolution
microscope (Thornwood, NY) with a 63 1.4 NA Zeiss PlanApo-
chromat oil immersion objective and processed using Slidebook software
(Intelligent Imaging Innovations, Denver, CO).
Time-Lapse Imaging
Live cells were held at 37°C using a microscope stage heater (Warner Instru-
ments, Hamden, CT). One of three microscopes was used for imaging. Time-
lapse images of tubules were captured using an inverted Olympus IX81
spinning disk microscope and a 60 1.4 NA Olympus oil immersion objective
(Olympus America, Melville, NY) with an attached Hamamatsu ORCA IIER
monochromatic CCD camera (Hamamatsu, Bridgewater, NJ). Cell surface
images were captured using an inverted Olympus IX81 Total Internal Reflec-
tion Fluorescence Microscope and a 60 1.45 NA Olympus TIRFM objective
(Olympus America). Photobleaching was performed on a Zeiss LSM 510 NLO
laser scanning confocal microscope using a PlanApochromat 63 NA 1.4 oil
immersion objective (Carl Zeiss International).
Images acquired on Olympus microscopes were acquired and processed
using Slidebook software as above. Quicktime movies were produced directly
from slidebook software and single frames were processed with Adobe
Photoshop 7 (Adobe Systems, Mountain View, CA). Images acquired on the
Zeiss 510 were acquired using Zeiss LSM Image Examiner and processed with
the same software or NIH ImageJ software (Rasband, 1997–2005).
Isolation of Membrane and Cytosolic Fractions
Rat liver stacked Golgi and cytosolic fractions were prepared as described
(Taylor et al., 1997) from control animals; i.e., rats were not treated with
cyclohexamide. For analysis of experiments in NRK cells, whole cell lysates
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from control and GFP-GMx33 transfected cells were prepared from dupli-
cate wells of a six-well plate. Cells were lysed in 1 ml cold lysis buffer (0.1 M
KH2PO4, 0.1 M K2HPO4, 5 mM MgCl2, 1% TX-100, pH 7.2) containing a
cocktail of protease inhibitors including: 1 mM phenylmethylsulfonyl fluoride
(PMSF) and 1 g/ml each of chymotrypsin, leupeptin, antipain, and pepsta-
tin. The lysed cells were mixed and then centrifuged at 16,100  g for 10 min
at 4°C and the supernatant was collected. For isolation of membranes and
cytosol from the same cell lines, cells from four wells of a six-well plate were
scraped with a rubber policeman in 1 ml of homogenization buffer (0.1 M
KH2PO4, 0.1 M K2HPO4, 5 mM MgCl2, 0.25 M sucrose, pH 7.2) and protease
inhibitors as above. The scraped cells were passed 15 times through a pre-
cooled ball bearing cell cracker and the homogenate was spun at 100,000  g
for 15 min at 4°C. The supernatant (cytosol) and pellet (membranes) were
collected. For direct analysis, membranes were solubilized in 1 ml of lysis
buffer and spun at 16,100  g for 10 min at 4°C to separate solubilized
membrane proteins (supernatant) from insoluble proteins (pellet).
Cytosolic Association and Membrane Budding Assays
Rat liver Golgi fraction and cytosol were maintained on ice or at 4°C through-
out the manipulations except where indicated. Golgi fractions were pelleted
and resuspended in the appropriate buffer, typically cytosol buffer (20 mM
HEPES, pH 7.4, 50 mM potassium acetate, 2 mM EDTA) containing 1 mM
PMSF. For high pH stripping, Golgi fractions were suspended in 200
mM sodium carbonate and incubated on ice for 20 min before being washed
in cytosol buffer. For salt stripping, an equal volume of 2 M KCl or 4 M NaCl
(final of 1 and 2 M, respectively) was added to the resuspended Golgi fraction,
which were then incubated for 1 h on ice before being pelleted at 16,100  g
for 20 min and washed in cytosol buffer. To test the association of cytosolic
GMx33 with the Golgi fraction, salt-stripped Golgi fractions were resus-
pended in cytosol buffer containing 1 mM PMSF at 300 g/ml (15 g of
membrane protein was used for each experimental group in 50 l of buffer).
Rat liver cytosol was precleared by ultracentrifugation (100,000  g for 20 min
in a Beckman TL-100 ultracentrifuge using a TLA100.3 fixed angle rotor;
Beckman Coulter, Fullerton, CA). Typically, 50 l (800 g) of precleared
cytosol was added to each experimental tube. For the indicated samples,
GTPS was added at a final concentration of 100 M (from 100 stock) and
ATP was added to a final concentration of 1 mM (from 100 stock). Whenever
ATP was added to a sample, an ATP-regenerating system was also added to
a final concentration of 8 mM creatine phosphate and 43 g/ml creatine
kinase (from 25 stock), except when ATP was specifically depleted. For ATP
depletion, ATP was added as above and a depleting system of glucose (5 mM
final concentration) and hexokinase (200 g/ml final concentration) replaced
the regenerating system. Samples were brought to a final volume of 120 l per
tube using cytosol buffer and were typically incubated for 30 min at 37°C in
an Eppendorf Thermomixer R (Eppendorf, Westbury, NY). After incubation,
samples were briefly cooled on ice and spun at 4°C at 16,100  g for 20 min
through a 0.5 M sucrose cushion to pellet the Golgi fractions and separate
them from cytosol. Pelleted fractions were washed 1 in cytosol buffer and
frozen until gel electrophoresis was performed. Typically one half of each
sample (7.5 g of starting membrane) was run on 10% SDS-polyacrylamide
gels.
Golgi budding assays were performed essentially as described (de Almeida
et al., 1993; Heimann et al., 1999). Briefly, 75 g of rat liver Golgi fraction was
suspended in HKM buffer (25 mM HEPES, pH 7.4, 20 mM KCl, 2.5 mM
magnesium acetate) and samples were maintained in 1 mM PMSF throughout
the assay. Buffer alone, ATP, and the ATP regenerating system with or
without GTPS were added to 4.5 mg of precleared cytosol in separate tubes
and maintained on ice until being added to the Golgi fractions. For GTPS
treatment, the Golgi fractions were incubated at 37°C with 100 M GTPS for
5 min before the addition of cytosol. Control and ATP-treated Golgi fractions
were incubated at 37°C for the same length of time, but in the absence of any
nucleotides. Cytosol mixtures containing nucleotides were then added to each
sample and the mixture was incubated at 37°C for 30 min as above. All final
concentrations were the same as above. After 30 min, samples were cooled on
ice for 10 min and remnant Golgi was separated from the budded fraction and
cytosol by a low-speed spin of 16,100  g for 20 min at 4°C. The supernatants
were then layered on top of a discontinuous sucrose gradient consisting of 2
M sucrose and 20% sucrose (diluted in HKM) and the samples were spun at
100,000  g for 90 min in a TLS55, swinging bucket rotor. The budded
fractions were recovered at the interface of the 2 M and 20% sucrose layers.
Typically one half of the budded fraction and one fifth of the remnant Golgi
was resolved using 10% SDS-PAGE gels.
For detergent and salt extractions of budded fractions or remnant Golgi
fractions, samples derived as above were incubated in HKM buffer contain-
ing: 1% Triton X-100 (Tx100) alone, 1% Tx100  150 mM NaCl, or 150 mM
NaCl alone for 30 min on ice. The unextracted material was then pelleted
(100,000  g for the budded fraction, 16,100  g for the remnant Golgi). All of
the budded fraction and one fifth of the remnant Golgi was used to resolve
proteins on SDS-PAGE gels.
For immunoblotting, proteins were transferred to nitrocellulose and
blocked in 5% defatted milk either overnight at 4°C or for 1 h at room
temperature. Monoclonal antibodies M3A5 (anti--COP; Allan and Kreis,
1986) and 166 (anti-pIgAR; Kuhn and Kraehenbuhl, 1983) and polyclonal
antibodies against p115 (kindly provided by Elizabeth Sztul, University of
Alabama, Birmingham AL) and p24 (kindly provided by John Bergeron,
McGill University, Montreal, Quebec, Canada) were used to probe mem-
branes after dilution in 1% milk. Primary antibodies were incubated for 1 h at
room temperature or overnight at 4°C. Antibodies were detected by enhanced
chemiluminescence (ECL) using HRP-conjugated anti-rabbit or anti-mouse
antibodies (both from Rockland, Gilbertsville, PA). ECL signal was detected
with ECL Western Blotting detection reagents and Hyperfilm ECL (both from
GE Health Care, Little Chalfont, Buckinghamshire, United Kingdom). Densi-
tometry of these signals was performed using NIH Image J software
(Rasband, 1997–2005). Alternatively, the Typhoon 9400 Variable Mode Imager
was used to detect fluorescent signal from anti-rabbit Alexa Fluor 633 or
anti-mouse Alexa Fluor 488.
Electron Microscopy and Immunogold Labeling
The budded fractions from 150 g of rat liver Golgi were prepared as above
and suspended in 50 l of HKM buffer. Ten microliters of sample was placed
onto the coated side of a formvar-coated/carbon-coated/glow-discharged
100-mesh copper-rhodium grid and allowed to settle (without drying) for 10
min. After settling, paraformaldehyde (Electron Microscopy Sciences, Wash-
ington, PA) was diluted in HKM buffer to 4% and 10 l was placed on each
grid to fix the samples. Grids were rinsed three times for 5 min each by
inversion over drops of PBS and samples were blocked with 10% FCS (Hy-
clone) in PBS for 30 min at room temperature. Antibodies for labeling were
diluted in 5% FCS in PBS. The primary antibodies (anti-GMx33 and human
anti-Golgin-245) and gold-labeled secondary antibodies were incubated se-
quentially on the grids for 1.5 h at room temperature. After each incubation,
grids were rinsed four times for 10 min each by inversion onto drops of PBS.
After the final wash, grids were rinsed twice with ddH2O and negative-
stained with a solution of 1% uranyl acetate and 1% methylcellulose for 30
min. The grids were air-dried and then exposed to vapors from 2% OsO4 for
10 min. Samples were observed with a Tecnai-12 electron microscope (FEI,
Hillsboro, OR) running at 80 keV. Images recorded digitally with a Gatan
2k  2k CCD camera using DigitalMicrograph software (Gatan, Pleasanton,
CA).
For tomographic imaging and 3D reconstruction, samples were prepared
on grids as above. The grid was placed in a Model 925 Double-Tilt Rotation
holder (Gatan) and viewed with an FEI Tecnai TF-20 FEG electron microscope
operating at 200 keV. The sample was tilted 60° and images were recorded
at 1° intervals with a pixel size corresponding to 0.45 nm. The grid was then
rotated and a similar tilt-series acquired about the orthogonal axis. Tilt-series
were acquired automatically using Serial-EM software. Tomograms of indi-
vidual labeled vesicles were calculated and analyzed with the IMOD software
package on a Macintosh G4 computer.
RESULTS
GFP-GMx33 Is Phenotypically Indistinguishable from
Endogenous GMx33
GMx33 is peripherally associated with the trans-Golgi
(Wu et al., 2000; Bell et al., 2001). To study GMx33 in more
detail, a GFP-GMx33 fusion construct was produced and
a stably transfected NRK cell line was established. GFP-
GMx33 is morphologically and biochemically indistin-
guishable from the endogenous protein (Figure 1). In both
nontransfected, control NRK cells and stably transfected
cells, GMx33 appears to almost colocalize with TGN38, a
trans-Golgi marker, but is slightly more peripheral than
TGN38 (Figure 1, A and B, top panels). The addition of 5
g/ml BFA for 10 min results in the appearance of
TGN38-positive tubules that are also positive for either
endogenous GMx33 (Figure 1A, bottom panels) or GFP-
GMx33 (Figure 1B, middle panels). A closer examination
of the tubules reveals that GMx33 and TGN38 do not
precisely overlap, but rather a portion of each resides in
distinct puncta along the length of the tubule, whereas
another portion appears to overlap (Figure 1, A and B,
insets). After 1 h of BFA treatment, both TGN38 and
GFP-GMx33 relocate to the region of the microtubule
organizing center, the so-called “BFA dot,” as previously
shown for endogenous GMx33 (Figure 1B, bottom panels;
Wu et al., 2000). Immunoblot analysis of GMx33 in trans-
fected and nontransfected cells reveals the existence of a
large (50%) cytosolic pool of both GFP-GMx33 and
endogenous GMx33 (Figure 1C). Finally, to demonstrate
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that GFP-GMx33 was indeed peripherally associated
with the Golgi, high salt washes were performed. Isolated
rat-liver Golgi fraction and a total membrane fraction
from GFP-GMx33-transfected cells were treated with 1
M KCl, resulting in 80 –90% of GMx33 being stripped
from the membrane of both samples (Figure 1D and quan-
titation in Figure 1E). Similar results were obtained after
treatment of Golgi fractions with 2 M NaCl (see Figure
5B). High pH also stripped GFP-GMx33 as expected
(Figure 1, D and E).
Cytosolic GMx33 Rapidly Exchanges with Membrane-
bound Protein
Like many Golgi matrix proteins, there is a large cytosolic
pool of GMx33 (50% of total protein, Figure 1C). To deter-
mine whether this pool exchanges with the membrane-
bound pool, the FRAP of GFP-GMx33 transfected cells was
measured. As shown in Figure 2, after bleaching the entire
Golgi region, GFP-GMx33 fluorescence rapidly returned to
the membrane with a t1/2 of 5.4 s. Maximal recovery was
achieved within 20–30 s. The recovery of GFP-GMx33 flu-
orescence was not dependent on microtubules because treat-
ment of the cells with 33.3 M nocodazole for 2 h resulted in
no significant change in the recovery half-time on Golgi
ministacks (Figure 2, A and B). Correlative experiments in
which the cytosol, but not the Golgi, was bleached repeat-
edly, ultimately led to fluorescence loss at the Golgi, con-
firming that Golgi-localized GMx33 exchanges rapidly
with its cytosolic pool (our unpublished data). As a compar-
ison, NRK cells were transfected with GFP-GRASP55 or
GFP-GRASP65, two Golgi matrix proteins with cytosolic
pools, one of which, GRASP65, has been previously shown
to rapidly exchange between Golgi-bound and cytosolic
pools (Ward et al., 2001). The fluorescence recovery of GFP-
GRASP65 and GFP-GRASP55 was slightly slower than that
of GFP-GMx33 in our hands, with t1/2s of 9.3 and 8.7 s,
respectively. As a control, cells were also transfected with
GFP-Golgin84, a transmembrane Golgi matrix protein with
no cytosolic pool, and bleached as above. As expected, these
cells showed little fluorescence recovery after photobleach-
ing, even after 1 h (our unpublished data). It is important to
note that the dynamics of the GFP-GMx33 membrane as-
sociation and dissociation may not precisely mimic those of
the endogenous protein, especially because the transfected
protein may have to compete with the endogenous protein
for Golgi binding. However, these data clearly demonstrate
the general phenomenon that GMx33 is extremely dy-
namic, rapidly cycling between membrane-bound and cyto-
solic pools.
GMx33 Traffics to Other Membranes in the Cell
When examining GFP-GMx33 by microscopy, we periodi-
cally observed small GFP-GMx33-positive structures near
the periphery of the cell that were clearly separate from the
Golgi. In some cases, these structures colocalized with en-
dosomal/lysosomal markers such as LAMPI (Figure 3B, top
panels). However, such colocalization was rare in control
cells. To determine if GFP-GMx33 could be trapped and
accumulated at any other membrane compartment besides
the Golgi, cells were first treated with inhibitors of endoso-
Figure 1. Endogenous GMx33 and GFP-
GMx33 are peripherally localized to the
TGN. (A) NRK cells were left untreated (top
panels) and treated with 5 g/ml brefeldin A
for 10 min (bottom panels), fixed, and stained
with antibodies specific for either TGN38 or
GMx33. Our GMx33-specific antibody recog-
nizes both  and  forms of GMx33. Primary
antibodies were detected with either anti-
mouse or anti-rabbit secondary antibodies
conjugated to either Alexa Fluor 488 or Alexa
Fluor 594. The inset is an enlarged image from
the area indicated by the dotted box. (B) NRK
cells stably expressing GFP-GMx33 were left
untreated (top panel) or treated with brefel-
din A for 10 or 60 min (middle and bottom
panels). Fixed cells were stained for TGN38.
The inset is an enlarged image from the area
indicated by the dotted box. (C) NRK cells
stably expressing GFP-GMx33 were lysed in
detergent (total) or used to prepare mem-
brane and cytosol fractions as described in
Materials and Methods. Protein (50 g per lane)
was analyzed by immunoblot with antibodies
specific for the indicated proteins. (D) Fifteen
micrograms of rat liver Golgi fraction were
left untreated or stripped with 1 M KCl for 1 h
on ice and washed (left panel). One hundred
micrograms of total membrane fractions from
wild-type NRK cells or those expressing GFP-
GMx33 (right panel) were left untreated or
stripped with 1 M KCl as above or a high pH
wash, 0.2 M sodium carbonate for 15 min on
ice. Half of each sample was subjected to SDS-
PAGE and analyzed by immunoblot with
antibodies specific for the indicated proteins. p24 and p63 proteins were followed as loading controls. (E) Densitometry was performed on
the immunoblots in D using the NIH Image J software. The amount of p24 or p63 signal in each lane was used to normalize slight differences
in loading. Bars, 10 m.
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mal acidification for 1 h. As shown in Figure 3, A and B,
ammonium chloride results in a dramatic expansion of
transferrin receptor-positive structures that normally reside
very close to the Golgi in NRK cells (Figure 3A, bottom
panels) and LAMPI-positive structures that are normally
distinct from the Golgi in NRK cells (Figure 3B, bottom
panels). The response of GFP-GMx33 to this treatment was
somewhat different. Nearly all of the transferrin receptor-
positive structures and many, but not all, of the LAMPI-
positive structures, even when significantly removed from
the peri-nuclear region (Figure 3, A and B, arrows) also
contained GFP-GMx33. These structures frequently stained
positive for TGN-38 as well, which has been previously
shown to migrate to endosomes after similar treatment
(Chapman et al., 1994; Reaves and Banting, 1994; and our
unpublished data). However, a portion of GFP-GMx33 also
remained in the peri-nuclear region and clearly no longer
colocalized with the transferrin receptor (arrowheads in Fig-
ure 3A, best seen in the merged image where no transferrin
receptor staining can be seen). This portion of GFP-GMx33
always colocalized with other Golgi markers such as
GM130, indicating that a portion of GMx33 was retained at
the Golgi under these conditions (our unpublished data). A
similar phenotype was observed in nontransfected cells and
also after treatment with alternative acidification inhibitors
monensin and chloroquine (our unpublished data). The fact
that the transferrin-receptor-positive and LAMPI-positive
structures are clearly distinct from the remnant Golgi indi-
cates that a pool of GFP-GMx33 is being recruited to these
peripheral structures and away from the Golgi.
To determine whether GMx33 or its binding partner(s)
were trapped in these structures, cells expressing GFP-
GMx33 were treated with ammonium chloride as above
and analyzed by FRAP. As shown in Figure 3C, after simul-
taneous photobleaching of both compartments, GFP-
GMx33 associated rapidly with enlarged endosomelike
structures (arrowhead) and remaining Golgi (arrow). These
data demonstrate that GMx33 interacting with two differ-
ent compartments continued to exchange with the cytosol
and implies that GMx33 can follow a binding partner or
partners to endosomal compartments.
To determine whether GMx33 localized to the plasma
membrane as well, total internal reflection fluorescence mi-
croscopy (TIR-FM) was used in control cells. Because there is
so much GFP-GMx33 in the cytosol, considerable back-
ground fluorescence was observed just beneath the plasma
membrane by TIR-FM. Nevertheless, as shown in Figure 4A
and Supplementary Video 1, GFP-positive vesicles could be
observed frequently at the plasma membrane. These vesicles
appeared at the plasma membrane and rapidly disappeared,
typically within 0.5–1.5 s. It is unclear whether these are
exocytic or endocytic events because we were never able to
clearly observe the GFP-GMx33 diffusing into the plane of
the plasma membrane. However, we often saw the GFP-
GMx33-positive vesicles moving laterally just before dis-
appearing.
To determine whether GFP-GMx33 could be accumu-
lated at the plasma membrane, we used inhibitors of endo-
cytosis. As shown in Figure 4B, potassium depletion and
hypotonic shock (middle panels) as well as cytosol acidifi-
cation (bottom panels), both induced the accumulation of
GFP-GMx33 associated with the plasma membrane. To-
gether these data indicate that GMx33 does indeed traffic to
the plasma membrane as well as to endosomes.
GMx33 Association with Golgi Can Be Regulated by
Either ATP or GTP
To determine the biochemical properties governing GMx33
association with the Golgi membrane, the rat liver Golgi
fraction was stripped with high salt (either 1 M KCl or 2 M
NaCl) and incubated with precleared cytosol in the presence
or absence of various nucleotides. Cytosol alone resulted in
binding of a negligible amount of GMx33 to the stripped
Golgi membranes. However, the presence of ATP and an
ATP-regenerating system resulted in binding of 10-fold
more GMx33 (Figure 5A), which was negated by the pres-
ence of an ATP-depleting system (Figure 5B). A nonhydro-
lyzable analog of ATP (ATPS) induced much less GMx33
binding (about threefold). Although GTP had no effect on
GMx33 binding (Figure 5A), GTPS induced an intermedi-
ate increase in GMx33 binding (about fivefold, Figure 5A).
This effect of GTPS was reproducible even in the presence
of an ATP-depleting system, indicating that the effect of
GTPS was independent of ATP (Figure 5C). A cis-Golgi
matrix protein, p115, showed no response to any nucleotide
tested (Figure 5A), whereas -COP was extremely respon-
sive to GTPS, as originally reported (Donaldson et al.,
1991a; Figure 5, A and B).
To determine the amount of cytosol necessary for GMx33
association with stripped rat liver Golgi fraction, cytosol was
titrated in the absence or presence of either GTPS or ATP.
At least 400 g of cytosol was required to detect a significant
Figure 2. GFP-GMx33 rapidly cycles be-
tween membrane and cytosolic pools. (A)
Cells stably or transiently expressing GFP-
GMx33 were left untreated (top panels) or
were treated with 33.3 M nocodazole for 2 h
at 37°C (bottom panels). The whole Golgi re-
gion or the indicated Golgi-stacklets were
bleached with the 488-nm laser set to 100%.
Approximately one image was captured each
second after bleaching and the fluorescence
recovery at 5 and 20 s is shown. The bottom
leftmost panel shows the entire cell. The re-
gion indicated by the white dotted box is
enlarged in the right three panels. (B) The
indicated number of cells transfected with GFP-GMx33, GFP-GRASP55, or GFP-GRASP65 were bleached and the average fluorescence
recovery after bleaching was graphed. The actual fluorescence intensity for each cell over time was converted to a percentage of the total
recovery. Fluorescence values obtained immediately after bleaching were used as 0%. One hundred percent recovery corresponds to the point
for each cell at which overall fluorescence no longer increased over time. Because of the rapid exchange of membrane and cytosolic
forms of GFP-GMx33, the cytosolic pool was bleached as it exchanged on the membrane during the bleaching period. Therefore, the
total fluorescence never recovered to the initial prebleach levels, and recovery level was inversely proportional to the time of bleaching.
Bars, 10 m.
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Figure 3. GMx33 can be “trapped” at endosomal membranes. (A)
NRK cells stably transfected with GFP-GMx33 were left untreated
or treated with ammonium chloride for 2 h before fixation and
staining. Cells were stained with an antibody specific for the trans-
ferrin receptor and DAPI. Arrows indicate enlarged endosomal
membranes positive for both GFP-GMx33 and the transferrin re-
ceptor. Arrowheads indicate GFP-GMx33 that is still associated
with the Golgi. Bar, 10 m. (B) Cells were treated as in A and stained
with an antibody specific for LAMP I and DAPI. Arrows indicate
LAMP I-positive membranes that are also positive for GFP-GMx33
in both control cells (top panels) and ammonium chloride treated
(bottom panels) cells. Bar, 10 m. (C) NRK cells stably transfected
with GFP-GMx33 were treated with ammonium chloride as in A
and B. An enlarged endosome (arrowhead) and an edge of the Golgi
(arrow) were both bleached as in Figure 2. The dotted box in the
leftmost top panel indicates the region enlarged in the other panels.
Bar in top leftmost panel, 10 m. Bar in bottom right panel, 3 m.
Figure 4. GFP-GMx33 can be found at the plasma membrane by
TIR-FM and can be trapped at the plasma membrane by inhibitors
of endocytosis. (A) NRK cells stably transfected with GFP-GMx33
were maintained at 37°C and visualized by TIR-FM over time. The
epifluorescent image of the entire cell is also shown (top left panel).
The bottom three rows show enlarged images of the boxed areas in
the top right-hand panel. Images were captured every 0.5 s. Arrows
and arrowheads point to GFP-GMx33-positive events at the
plasma membrane. This localization is transient. These events are
seen more clearly in Supplementary Video 1. Bar in top panels, 10
m; bars in bottom panels, 3 m. (B) NRK cells stably transfected
with GFP-GMx33 were left untreated or were cultured in the
presence of a K-depleting buffer or acidic (pH 5) media. Cells were
fixed and stained with antibodies specific for TGN38 before imag-
ing. Bars, 10 m.
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amount of GMx33 binding over background (Supplemen-
tary Figure 1). In comparison, significant -COP association
with stripped Golgi membranes was detectable with 100
g of cytosol in the same assay. Finally, to determine
whether GMx33 spontaneously disassociates from mem-
branes, Golgi fractions were suspended in cytosol buffer
without salt and incubated for 10-min intervals at 37°C. The
Golgi fractions were pelleted at 4°C between each incuba-
tion. As shown in Figure 5D, GMx33 dissociated slowly
under these conditions. After four washes, 50% of the
original GMx33 signal remained associated with the Golgi
membranes. Because these dissociation assays were per-
formed in the absence of cytosol, we would not necessarily
expect the rate of dissociation observed here to be identical
to that seen in the in vivo FRAP experiments (Figure 2),
especially if a cytosolic component is essential to rapidly
remove GMx33 from the membrane. However, given that
our antibody recognizes both GMx33 and , it is also
possible that these two isoforms behave with different kinet-
ics, making the dissociation of GMx33 as observed by im-
munoblot of rat liver fractions, which contain both isoforms,
slower than that of GMx33 alone as observed in transfected
NRK cells.
GMx33 Exits the Golgi in Tubules
To further observe the dynamic nature of GMx33, live cell
imaging was performed. Short tubules emerged from the
Golgi in nearly every cell (Figure 6A) and in all cases, after
a few seconds GFP-GMx33 segregated into puncta along
the length of the tubule. In some instances these puncta
separated dramatically, appearing to break off into shorter
tubular or vesicular structures before moving throughout
the cell (Figure 6A and Supplementary Video 2). The tubules
moved relatively rapidly, emerging and separating in less
than 1 min. Similar structures also could be observed ex-
tending from the “BFA dot” after 1 h of BFA treatment.
These data indicate that Arfs, Arls, and coatomer are not
required for GMx33 tubule formation, because BFA has been
shown to dissociate all three from the Golgi membrane
(Figure 6B and Supplementary Video 3).
In fixed cells the GFP-GMx33-positive tubules were ob-
served and were frequently (Figure 6C, top panels), but not
always (bottom panels) positive for TGN38. As in BFA-
treated cells (Figure 1, A and B), the GFP-GMx33 and
TGN38 appeared to segregate into puncta along the length
of the tubules that only partially overlapped (Figure 6A,
rightmost panels). Similar results were observed in non-
transfected cells. These data suggest that GMx33 exits the
Golgi associated with tubules.
GMx33 Associates with Tethers Attached to Budded
Vesicles
Seeing GMx33-positive tubules leaving the Golgi was sur-
prising, because GMx33 did not move to a budded mem-
brane fraction in our standard budding assay (Wu et al.,
2000). However, only ATP, not GTPS, was used in the
original experiments. Because our data indicate that GMx33
can associate with Golgi fraction in the presence of GTPS
(Figure 5), it is possible that, like coatomer (Donaldson et al.,
1991a, 1991b), GMx33 dissociates from budded vesicles in
a GTP-dependent manner. To test this, a budding assay
was performed with rat liver Golgi fraction in the pres-
ence or absence of GTPS. As expected, budded mem-
branes recovered in the presence of cytosol alone, or
cytosol with ATP and an ATP-regenerating system had no
detectable, or extremely small amounts of GMx33 associ-
ated (Figure 7A). Strikingly however, in the presence of
both ATP and GTPS we easily detected GMx33 in the
budded fraction. Therefore, GMx33 associates with bud-
ding membranes in a GTP-dependent manner and GTPS
stabilizes this interaction.
If GMx33 is associating with the budded fraction in the
presence of GTPS, this could explain the fact that GTPS
did not promote as much GMx33 association with stripped
membranes as ATP (Figure 5A). This budded fraction was
not recovered in the original assay because of the low-speed
Figure 5. Cytosolic GMx33 associates with
stripped membranes in a GTP- or ATP-de-
pendent manner. (A) Rat liver Golgi fraction
was stripped with 1 M KCl, split into 15 g
aliquots, and incubated with cytosol (800 g
per aliquot) for 30 min with the indicated
treatment as described in Materials and Meth-
ods. Half of each sample was analyzed by
immunoblot with antibodies against the fol-
lowing proteins: -COP, p115, GMx33, and
p24. For densitometry, the GMx33 signal was
standardized to the signal for the Golgi-trans-
membrane protein, p24, and the data are in
the bottom part of the panel. (B) Rat liver
Golgi fraction was stripped with 2 M NaCl.
Cytosolic proteins were incubated with the
stripped membrane in the presence of the
indicated nucleotides and samples were ana-
lyzed as in A. (C) Rat liver Golgi fraction was
stripped as in A and treated as indicated with
the indicated nucleotides. (D) Rat liver Golgi
fraction was not stripped and was subjected
to the indicated number of washes at 4°C.
Between each wash the fraction was incu-
bated in cytosol buffer for 10 min at 37°C. The
final membrane pellets were immunoblotted
with antibodies specific for GMx33 and p24.
Quantitation was performed as in A and is
provided below the blot.
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centrifugation used to pellet the stacked Golgi fraction. To
test this, rat liver Golgi membranes were stripped as before
and the association of GMx33 from the cytosol was mea-
sured over time. Both ATP and GTPS induced rapid asso-
ciation with stripped Golgi membranes to an approximately
equal degree. However, although the presence of ATP
caused GMx33 to remain associated with Golgi for the entire
30-min time course, the total amount of GMx33 associated
with recovered Golgi steadily decreased in the presence of
GTPS, indicating that the GMx33 that had bound to the
Golgi was leaving over time on the exiting tubules or vesi-
cles (Supplementary Figure 2).
To identify what GMx33 was associating with in these
experiments, the budded fraction was examined by EM
after immunolabeling for GMx33. In the presence of
GTPS, much more GMx33 associated with the budded
fraction (our unpublished data), confirming the immuno-
blot results. GMx33 was localized to the outside of bud-
ded vesicles (Figure 7B), which, by morphology, were
either surrounded by a dense, coatlike structure or were
uncoated. Strikingly however, the primary structure la-
beled by the GMx33 specific antibodies was a “matrix-
like,” osmophilic structure associated with the vesicles.
This matrix was often connecting two or more vesicles
and labeled with multiple GMx33 antibody-gold com-
plexes (Figure 7B). In addition, many of these matrixlike
structures were present independent of vesicles (Figure
8B, panel g). 3-D tomography revealed no discernable
Figure 6. GFP-GMx33 exits the Golgi in
tubules. (A) NRK cells stably expressing GFP-
GMx33 were held at 37°C and visualized by
time-lapse imaging every 7 s. Shown is a pair
of tubules extending from the Golgi that frag-
ment into short tubules or vesicles between 28
and 42 s. The left panel shows the whole
Golgi; the right panels are enlarged images of
the region indicated by a dashed box. Bar in
leftmost panel, 10 m; in enlarged images, 2
m. (B) NRK cells stably expressing GFP-
GMx33 were treated with brefeldin A for 1 h
and visualized by time-lapse imaging as in A.
Shown is a whole cell just before tubule
formation and enlarged images of the re-
gion outlined by the dotted box in the top
leftmost panel. Bar in the leftmost top panel,
10 m; in the enlarged images, 3m. (C)
NRK cells stably transfected with GFP-
GMx33 were fixed and stained with anti-
bodies specific for TGN38. Two cells with
tubules extending from the Golgi are
shown. Bars, 10 m.
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membranes within these matrixlike structures, which ap-
peared to be contiguous with the coats surrounding the
vesicle membrane (Supplementary Videos 4 and 5). Mor-
phometric analysis showed that GMx33 almost exclu-
sively (97%) associated with these matrixlike structures
(Supplementary Figure 3). In rare instances when the gold
label looked to be directly associated with a vesicle, there
typically was a small matrix-piece that surrounded or
attached to the same or another part of the vesicle (Figure
7B, a, h, and k). As an antigen is localized within 15–18 nm
of the gold particle (Griffiths, 1993), because of the length
of the two IgG molecules, it is difficult to determine where
the coat ends and matrixlike structures begin.
GMx33 Associates with the Golgi Matrix
The structures that labeled with the GMx33-specific antisera
are very similar to those previously described to contain
p230/Golgin-245, a GRIP-domain containing Golgi matrix
protein (Gleeson et al., 1996). To investigate whether these
were the same structures, a budded vesicle fraction was
colabeled with GMx33 and Golgin-245-specific antisera and
both antibodies labeled nearly identical structures (Figure
8A). The same structures were sometimes double-labeled
(Figure 8, B and C) and often the label was on two different
matrix-pieces associated with the same vesicle as shown
both in negative stain and 3-D tomography (Figure 8B, c and
f, and 8C and Supplementary Video 6). These data indicate
that GMx33 is associated with the trans-Golgi matrix on
budded vesicles.
To verify that these two proteins could be found on tu-
bules exiting the Golgi, fixed cells were stained with p230/
Golgin-245-specific antisera. Both GFP-GMx33 and Golgin-
245 could be found on the same tubules and both segregated
into puncta along the length of the tubule (Figure 8D).
Figure 7. GMx33 associates in a GTP-de-
pendent manner with matrixlike structures
attached to vesicles in a budded vesicle frac-
tion. (A) Rat liver Golgi fraction (75 g) was
incubated with 4.5 mg cytosol and the indi-
cated nucleotides for 30 min at 37°C and rem-
nant Golgi and budded fractions were sepa-
rated as described in Materials and Methods.
Protein was analyzed by immunoblot with
antibodies specific for GMx33, -COP, and
pIgA receptor (a cargo molecule moving to
the plasma membrane). (B) Budded fractions
were prepared as in A in the presence of ATP
and GTPS, placed on an EM grid, and im-
munolabeled with antibodies specific for
GMx33. Shown are 11 different examples of
budded vesicles associated with electron
dense (osmophilic) “tails” that are positive
for GMx33. Some of these tails appear to con-
nect adjacent vesicles (b, c, g, j, and k). The
gold particles lie almost exclusively within
the tail material and are distinct from the
vesicles’ membranes. Bars, 100 nm.
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Although the two proteins showed some regions of overlap on
the tubules, there were also regions of unique localization.
Because GMx33 and Golgin-245 sort into these puncta along
tubules (Figures 6 and 8) and do not associate with the mem-
branes of budded vesicles, but rather the matrixlike “tails” as
observed by EM (Figures 7 and 8) and because GMx33 and
TGN38 often appear to be in distinct puncta along naturally
occurring tubules (Figure 6C) and those formed by BFA treat-
ment (Figure 1), our data suggest that matrix sorts away from
transmembrane proteins within tubules.
Figure 8. GMx33 associates with the trans-
Golgi matrix and colocalizes with p230/Gol-
gin-245 in tubules exiting the Golgi. (A) Bud-
ded fractions were immunolabeled on EM
grids as in Figure 7 with antibodies specific for
p230/Golgin-245. Shown are eight different
examples of Golgin-245-positive electron
dense (osmophilic) “tails” associated with the
budded vesicles. Bars, 100 nm. (B) Budded
fractions were prepared as in A and probed
with antibodies specific for p230/Golgin-245
(15 nm gold) and GMx33 (10 nm gold). Shown
are eight examples of structures, both vesicles
and matrix alone (g) that colabeled for both
proteins. Bars, 100 nm. (C) A vesicle that cola-
beled with antibodies for GMx33 and Golgin-
245 was analyzed by 3-D tomography. Shown
are five tomographic slices (0.45 nm) through
the volume of the vesicle. Gold particles cor-
responding to the two antigens are localized to
the electron-dense matrix material surround-
ing the vesicle and both are distinct from the
vesicle membrane itself. Bar, 100 nm. (D) NRK
cells stably transfected with GFP-GMx33
were fixed and labeled with antibodies specific
for p230/Golgin-245 and fluorophore-conju-
gated secondary antibodies. The top panels
show that there is good, but not perfect colo-
calization between GMx33 and Golgin-245.
The bottom two panels show a tubule extend-
ing from different cells. The boxed regions in
the leftmost panels depict the areas enlarged in
the subsequent panels. Bars, 10 m.
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GMx33 Is an Atypical Golgi Matrix Protein
Inhibition of GRIP protein function by specific antibodies
(Lu et al., 2004) or overexpression of either a GRIP domain
alone or the GRIP domain protein GCC88 has been shown to
disrupt the trans-Golgi structure (Luke et al., 2003; Yoshino et
al., 2003). To determine whether depletion of GMx33 would
also lead to Golgi fragmentation, we treated NRK cells with
siRNA specific for GMx33 and GMx33 individually or
together. GMx33-specific siRNA depleted the majority of
GMx33 expression (Figure 9A). By comparison GMx33-
specific or lamin-specific siRNA had no detectable effect on
the overall GMx33 signal by immunofluorescence or immu-
noblot (our unpublished data). Our antisera recognizes both
GMx33  and , indicating that GMx33 is the predominant
form expressed by NRK and HeLa cells. Even when all
detectable GMx33 has been depleted, no major changes in
the Golgi structure were obvious by immunofluorescence
(Figure 9A). These data indicate that although GMx33 asso-
ciates with the trans-Golgi matrix in a GTP-dependent man-
ner, Golgi structure is not disrupted in a significant way and
therefore GMx33 may not be a “classical” trans-Golgi matrix
protein.
Because the Golgi matrix was originally defined as insol-
uble in Tx100 and partially resistant to extraction by Tx100
plus 150 mM NaCl, both the budded fraction and the re-
maining Golgi were submitted to these conditions, and the
resultant fractions wee pelleted and analyzed by immuno-
blot. In both fractions GMx33 was predominantly insoluble
in 1% Tx100, whereas greater that 75% of the GMx33 was
extracted with 1% Tx100 plus 150 mM NaCl. These biochem-
ical properties are hallmarks of Golgi matrix proteins.
DISCUSSION
GMx33 is dynamically associated with the trans-Golgi ma-
trix, associating and dissociating with the Golgi in seconds.
GMx33 can be locked onto the trans-Golgi matrix by GTPS,
indicating that its association is regulated in a GTP-depen-
dent manner like many other Golgi matrix proteins (Barr
and Short, 2003; Jackson, 2003; Gleeson et al., 2004). Using
live-cell imaging, we show that GFP-GMx33 exits the Golgi
in tubules and within the tubules the GFP-GMx33 appears
to segregate from transmembrane proteins followed by frag-
mentation of the tubules into smaller tubules and vesicles.
Within vesicles produced in an in vitro budding reaction,
GMx33 remains segregated in a matrixlike tail region that
also contains Golgin-245, and this trans-matrix often links a
few vesicles together. Together this data suggests that
GMx33 is a member of the trans-Golgi matrix and may
participate in sorting and exit from the Golgi.
GMx33 and  were identified as unknown proteins in an
effort to define the Golgi proteome and characterized to be
detergent insoluble, predominately localized to the trans-
Golgi but having a large cytoplasmic pool (Wu et al., 2000).
The Golgi bound and cytosolic pools are differentially post-
translationally modified. The human orthologues of GMx33,
GPP34, and GPP34R were identified in an independent pro-
teomic study of the Golgi and were shown to associate with
the cytoplasmic face of the trans-Golgi (Bell et al., 2001).
Neither isoform contains strong homology to previously
known domains. GMx33 has limited similarity to GRIP
domains, but mutagenesis studies have indicated that
GMx33 is not a GRIP protein since the putative GRIP
domain is not sufficient for Golgi localization (our unpub-
lished data). Despite significant homology between the 
and  isoforms, there are regions that are not shared and
these will be useful for teasing apart the individual function
of each. Our data suggest that GMx33 is the dominant
isoform expressed in NRK and HeLa cells because alpha-
specific siRNA reduced almost all detectable GMx33 expres-
sion, whereas beta-specific siRNA had no detectable effect
(our unpublished data).
The homologous proteins to GMx33 have been deleted
from yeast (vps74; Bonangelino et al., 2002) and Drosophila
(l(2)s5379; Spradling et al., 1999) and depleted from Caeno-
rhabditis elegans (Y47G6A; Fraser et al., 2000), in broad dele-
tion studies. Although the absence of GMx33 in Drosophila
and C. elegans offers few clues as to its function, in yeast,
where there is only a single form, Vps74p, deletion resulted
in a modest mis-sorting and secretion of the vacuolar protein
carboxypeptidase Y. Additionally, an interaction between
Vps74p and Vps26p, a member of the yeast retromer com-
Figure 9. Depletion of GMx33 does not visibly disrupt the Golgi
structure even though GMx33 has the biochemical properties of the
Golgi matrix. (A) NRK cells were transfected with siRNA specific
for GMx33, incubated for 96 h, and stained with antibodies specific
for GMx33 and the indicated marker protein. Each image includes
cells that continued to express GMx33 for comparison. Bar, 10 m.
(B) Budded fractions were isolated from 75 g rat liver Golgi
fraction in the presence of ATP and GTPS. After isolation, the
pelleted budded fractions or remnant Golgi fractions were analyzed
directly () subjected to extraction with 1% Tx100 alone, 1% Tx100
 150 mM NaCl, or 150 mM NaCl alone for 30 min on ice. Each
sample was then pelleted again and protein was analyzed by im-
munoblot with antibodies specific for GMx33.
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plex, was reported (Bonangelino et al., 2002), which is inter-
esting in light of our evidence that GMx33 can be localized
to and trapped on both endosomal and the plasma mem-
branes. Because there is a large cytosolic pool of GMx33, it is
possible that GMx33 from the cytosol is simply binding to
various membranes directly from the cytosol as its binding
partners or ligands traffic. This idea is supported by our
finding that even after treatment of cells with inhibitors of
endosomal acidification, GFP-GMx33 continues to cycle
rapidly between the membrane-bound and cytoplasmic
pools. Similar experiments have not been carried out on
other Golgi matrix proteins, so it is possible they also asso-
ciate dynamically with membrane compartments other than
the Golgi. Our preliminary results suggest that Golgin-245
does not follow the same pathway as GMx33.
GMx33 is highly posttranslationally modified (Wu et al.,
2000). Phosphorylation is known to regulate several Golgi
matrix proteins and membrane bound GMx33 is phosphor-
ylated, whereas cytosolic GMx33 seems to lack the phos-
phorylated modifications (Barr et al., 1997; Nakamura et al.,
1997; Lowe et al., 1998; Dirac-Svejstrup et al., 2000; Lowe et
al., 2000; Wu et al., 2000; Brandon et al., 2003; Wang et al.,
2005). ATP promotes GMx33’s Golgi association and it is
likely that this association involves phosphorylation. The
role of GTP in regulating the Golgi matrix as a whole is
clearly multifactorial and Rab, Arf, and Arl GTPases are
known to function in the regulation of Golgi matrix mem-
brane association and tethering and perhaps the regulation
of conformation to govern the specificity of interactions
(Barr and Short, 2003; Jackson, 2003; Gleeson et al., 2004).
Given this, it is not surprising that GTP plays a role in
regulating GMx33’s Golgi association, even though we were
not able to detect similar regulation of the cis-Golgi matrix
protein p115 with these conditions (Figure 5A). GMx33 itself
is not predicted to bind to GTP and its Golgi association is
not disrupted by BFA, ostensibly eliminating Arl1 and Arf1
as possible binding partners. Therefore, it is likely that
GMx33 is regulated by a Rab GTPase and GTPS is simply
locking GMx33 onto the trans-Golgi matrix. At this time, we
cannot rule out the possibility that there are two pools of
membrane bound GMx33, one regulated by ATP and phos-
phorylation and a second regulated by GTP, especially be-
cause there are two isoforms of the protein,  and , and
each isoform could be regulated differently.
Golgi matrix proteins are considered to be important for
maintaining the structure of the Golgi. The GRASP proteins
have been shown to stack Golgi cisternae in vitro (Barr et al.,
1997; Shorter et al., 1999). Cleavage of Golgi matrix proteins
by caspases is essential for Golgi fragmentation during ap-
optosis (Mancini et al., 2000; Chiu et al., 2002; Lane et al.,
2002). Inhibition of Golgin-97 by specific antibodies results
in Golgi fragmentation (Lu et al., 2004), whereas overexpres-
sion of GCC88 resulted in accumulation of large matrix-rich
domains, termed “cauliflowers” in the trans-Golgi region
(Luke et al., 2003) and overexpression of the GRIP domain of
p230/Golgin-245 resulted in perturbations in the trans-Golgi
(Yoshino et al., 2003). These effects may be indirect however
because depletion of Golgin-97 by RNA interference did not
result in any obvious structural changes in the Golgi by light
microscopy (Lu et al., 2004). These data and our findings that
depletion of GMx33 does not appear to affect the structure of
the Golgi by light microscopy suggest a subtle role for these
proteins in maintenance of the trans-Golgi. It is interesting to
note that although some bacteria may have proteins related
to GMx33 as defined by low (109 and 1011) E values in a
BLAST search, plants do not seem to have any proteins
related to GMx33, supporting the idea that it is not required
for maintaining Golgi structure.
The presence of GMx33 on tubules exiting the Golgi is
striking. All GMx33-positive tubules observed show distinct
puncta of GMx33 along the length of the tubule and these
puncta do not precisely colocalize with TGN38 in fixed cells.
Only one other trans-Golgi matrix protein, p230/Golgin-245,
has been shown to associate with vesicles and tubules exit-
ing the Golgi (Brown et al., 2001; Gleeson et al., 2004). Both
GMx33 and Golgin-245 appear in puncta along tubules, and
both proteins associate with similar matrix structures after a
standard budding assay from an isolated Golgi fraction. Our
hypothesis is that during tubulation, transmembrane pro-
teins are sorted from matrix within the tubules. Our EM data
further suggests that the Golgi matrix may tether these
sorted vesicles together for some time along the length of
tubules, before fission. This suggests an interesting role for
the trans-Golgi matrix proteins in tubulation and sorting in
exit from the Golgi.
The Golgi matrix has been classically defined as a deter-
gent-insoluble and salt-resistant group of proteins that bind
to resident Golgi transmembrane proteins and regulate the
structure of the Golgi stack. GM130, the prototypical Golgi
matrix protein, is 80% insoluble in Tx100, and 35% of the
protein is resistant to extraction by 1% Tx100 in 150 mM
NaCl (Slusarewicz et al., 1994). Similarly, GMx33 is also
mostly resistant to solubilization in 1% Tx100, especially
when associated with the Golgi matrix in a budded fraction
(Figure 9B). The addition of 150 mM NaCl to the 1% Tx100
increases the efficiency of the GMx33 extraction from the
matrix, but GMx33 is clearly salt sensitive (Figure 1D), so
this is not surprising.
As more Golgi matrix proteins have been discovered, long
coiled-coil domains have been defined as a common struc-
tural feature. Many of these proteins are targets of autoan-
tibodies and have been termed Golgins (Nozawa et al., 2005).
GMx33 is not predicted to have an extensive coiled-coil
structure, although it may have three coiled domains, and
by this definition it is not a Golgin (Barr and Short, 2003).
However, GRASP65 and GRASP55, two matrix proteins in-
volved in maintaining the Golgi stack (Barr et al., 1997;
Shorter et al., 1999), are also not predicted to be highly coiled
(Gillingham and Munro, 2003), but are sometimes catego-
rized as Golgins (Barr and Short, 2003).
The functions of the trans-Golgi matrix are poorly under-
stood. Much of what we know has come from studies char-
acterizing the individual matrix proteins and that data have
been used to predict functions. These predicted functions
include a role in both anterograde and retrograde trafficking
as well as interactions with the cytoskeleton and mainte-
nance of Golgi structure (Erlich et al., 1996; Matanis et al.,
2002; Luke et al., 2003; Yoshino et al., 2003; Kakinuma et al.,
2004; Lu et al., 2004; Yoshino et al., 2005). As other proteins
are characterized, the predicted functions will be modified
to include the new data. One such protein is GMx33, which
has the biochemical properties of a matrix protein and asso-
ciates dynamically with the trans-Golgi matrix. Its presence
on tubules exiting the Golgi and its localization within seg-
regated puncta on these tubules, as well as its localization to
endosomes and the plasma membrane offer clues about the
role that GMx33, and perhaps other trans-Golgi matrix pro-
teins, play in several basic sorting processes.
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